Mustang Bio, Inc.
COMBINATION THERAPY COMPRISING CANCER-TARGETED CAR-T CELLS AND A METHOD OF USING SAME FOR A TREATMENT FOR CANCER

Last updated:

Abstract:

Described are improved methods for treating solid tumors, such as malignant gliomas, with a dual approach utilizing a CAR-T immunotherapy and a viral oncolytic therapy.

Status:
Application
Type:

Utility

Filling date:

9 Sep 2021

Issue date:

10 Mar 2022